Sale or disposal

Rainbow® Children's ~ BirthRighf Hospital ~ - BY RAINBOW HOSPITALS WOMEN CARE I CHILD CARE I FERTILITY July 29, 2026 National Stock Exchange of India Limited BSE Limited Exchange Plaza, Plot No. C/1, G Block, Corporate Relationship Department, Bandra Kurla Complex, Bandra (E), Phiroze Jeejeebhoy Towers, Mumbai – 400 051. Dalal Street, Mumbai – 400001. Symbol: RAINBOW Scrip Code: 543524 Sub: Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI Listing Regulations") Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI Listing Regulations"), this is to inform you that the Company has executed the definitive transaction documents, including a Shareholders' Agreement ("Transaction Documents"), in connection with the the proposed capacity addition through development of a new children and women’s hospital at Malad, Mumbai through its wholly owned subsidiary, Rainbow Women & Children's Hospital Private Limited ("RWCHPL"), involving an estimated project cost of approximately ₹90 Crore. The proposed project is expected to augment the Company's healthcare delivery network and expand its operational capacity. The Transaction Documents, inter alia, provide for the induction of Fountainhead TCHM Healthcare LLP ("LLP") in RWCHPL and set out the terms and conditions governing the rights and obligations of the parties in relation to the proposed investment and the implementation of the proposed project. Fountainhead TCHM Healthcare LLP is promoted by group of reputed doctors namely Dr. Susan Veena Fernandes, Dr. Vinay Hanamesh Joshi and Dr. Allan Mark Pereira. Pursuant to the Transaction Documents, the LLP is proposed to acquire a 24% equity stake in RWCHPL, subject to the terms and conditions set out therein. Upon completion of the transactions contemplated under the Transaction Documents, RWCHPL shall cease to be a wholly owned subsidiary of the Company and shall continue as a subsidiary of the Company, with the Company holding 76% of the equity share capital of RWCHPL and continuing to retain control over RWCHPL. The details required under Regulation 30 of the SEBI Listing Regulations read with Schedule III thereto and the SEBI Master Circular dated January 30, 2026, are enclosed as Annexure A, Annexure B and Annexure C. Rainb ow Children's Medicare Lim ited Registered Office: 8-2-120/103/1, Survey No. 403, Road No. 2, Banjara Hills, Hyderabad- 500034, Telangana CIN :L85110TG 1998PLC029914 Q Corporate Office: 8-2-19/1/A, Daulet Arcade, Road No. 11, Banjara Hills, Hyderabad- 500034, Telangana G info@rainbowhospitals.in \;' 1800 2122 iffil www. rainbowhospitals.in OUR PRESENCE: BENGALURU CHENNAI DELHI GUWAHATI HYDERABAD RAJAHMUNDRY VIJAYAWADA VISAKHAPATNAM WARANGAL The above information will also be available on the website of the Company at https://www.rainbowhospitals.in/investors-relations/stock-exchange-disclosures. This is for your information and record. Thanking You, Yours Faithfully, For Rainbow Children’s Medicare Limited Shreya Mitra Company Secretary and Compliance Officer Encl.: As above Annexure A Disclosure relating to Capacity Addition Sr. No. Particulars Details 1. Existing capacity As on date - 2,435 beds. 2. Existing capacity utilisation As on date - 46.3% 3. Proposed capacity addition Development/establishment of the proposed children’s and women’s hospital at Malad, Mumbai resulting in an incremental capacity of 100 beds. 4. Period within which the proposed The proposed capacity is expected to be capacity is to be added commissioned by Q1 FY27-28, subject to receipt of necessary approvals and completion of construction/development activities. 5. Investment required Approximately ₹90 Crore (~₹68,40,00,000 will be contributed by RCML). 6. Mode of financing Internal Accruals 7. Rationale The proposed capacity addition will further enhance the Company's ability to deliver specialized pediatric, women, and neonatal care across Maharashtra. The addition of the 100-bed brownfield hospital in Malad, Mumbai (expected to commence operations in Q1 FY28) complements the previously announced 150-bed regional hub in Pune (expected to commence operations in FY29). Together, these facilities will establish a strong regional hub-and-spoke network across the Maharashtra state, expanding the Company's presence in Western India, improving patient access, strengthening referral pathways, and creating a scalable platform for long-term growth in one of India's largest healthcare markets. Annexure – B Disclosure in relation to Transfer of Equity Shares Sr. Particulars (as per SEBI Details No. disclosure requirements) 1 The amount and percentage of the turnover or revenue or income and • Turnover contributed in FY 2025-26: Nil net worth contribution of the subsidiary during the last financial • Net Worth contribution as of March 31, 2026: year ₹ (0.003) Crore 2 Date on which agreement for sale Not Applicable has been entered into 3 Expected date of completion of On or before August 31, 2026. sale/disposal 4 Consideration received from such ₹24,000 sale/disposal 5 Brief details of buyers and whether Fountainhead TCHM Healthcare LLP any of the buyers belong to the promoter/promoter group/group The buyer does not belong to promoter/ promoter companies. If yes, details thereof group/group companies 6 Whether the transaction would fall Not Applicable within related party transactions? If yes, whether the same is done at arm's length 7 Whether the sale, lease or disposal of Not Applicable the undertaking is outside a Scheme of Arrangement? If yes, details of the same include compliance with regulation 37A of LODR Regulations 8 Additionally in case of a slump sale, Not Applicable indicative disclosures provided for amalgamation/merger, shall be disclosed by the listed entity with respect to such slump sale 9 Details and reasons for restructuring With a view to jointly developing and operating the proposed Children’s and Women’s Hospital at Malad, Mumbai, Fountainhead TCHM Healthcare LLP, promoted by the aforesaid group of doctors, is proposed to be inducted as an equity investor in RWCHPL. 10 Quantitative and /or qualitative effect RCML will dilute 24% stake in RWCHPL. of restructuring 11 Details of benefit, if any, to the promoter/promoter group/ group Nil. companies from such proposed restructuring 12 Brief details of change in shareholding pattern (if any) of all RCML will dilute 24% of its shareholding in entities RWCHPL and it will be transferred to Fountainhead TCHM Healthcare LLP. Post shareholding will be as mentioned below: Sr. Name of No. of % of No. Shareholder Shares shareholding 1 Rainbow 7,600 76% Children’s Medicare Limited 2 Fountainhead 2, 400 24% TCHM Healthcare Annexure – C Disclosure in relation to Acquisition (Investment in Securities) Sr. No. Particulars Details 1. Name of the target entity, details in Name: Rainbow Women & Children's Hospital brief such as size, turnover etc. Private Limited ("RWCHPL") is engaged in managing, running hospitals, dispensaries, maternity homes, health centers, clinics and diagnostic centers for providing medical servies, surgery and other allied services in all the branches. CIN: U85100TG2010PTC071633 Authorized Capital: ₹50,00,000/- Paid-up Capital: ₹1,00,000/- The turnover of Target Company for FY (25- 26): Nil 2. Whether the acquisition would fall Except for directorship, the Promoter, Promoter within related party transaction (s) Group and Group Companies have no interest and whether the promoter/ promoter in RWCHPL. The proposed investment shall be group/ group companies have any made on an arm's length basis through interest in the entity being acquired? subscription to the securities of RWCHPL in If yes, nature of interest and details multiple tranches, as may be mutually agreed thereof and whether the same is between the parties, based on the funding done at “arm’ [Showing first 8,000 characters — download PDF for full document]